| Literature DB >> 30596673 |
Vaishnavi Pattabiraman1, Lee S Katz1,2, Jessica C Chen1, Andre E McCullough3, Eija Trees1.
Abstract
Enterotoxigenic Escherichia coli (ETEC) are an important cause of diarrhea globally, particularly among children under the age of five in developing countries. ETEC O6 is the most common ETEC serogroup, yet the genome wide population structure of isolates of this serogroup is yet to be determined. In this study, we have characterized 40 ETEC O6 isolates collected between 1975-2016 by whole genome sequencing (WGS) and by phenotypic antimicrobial susceptibility testing. To determine the relatedness of isolates, we evaluated two methods-whole genome high-quality single nucleotide polymorphism (whole genome-hqSNP) and core genome SNP analyses using Lyve-SET and Parsnp respectively. All isolates were tested for antimicrobial susceptibility using a panel of 14 antibiotics. ResFinder 2.1 and a custom quinolone resistance determinants workflow were used for resistance determinant detection. VirulenceFinder 1.5 was used for prediction of the virulence genes. Thirty-seven isolates clustered into three major clades (I, II, III) by whole genome-hqSNP and core genome SNP analyses, while three isolates included in the whole genome-hqSNP analysis only did not cluster with clades I-III by both analyses and formed a distantly related outgroup, designated clade IV. Median number of pairwise whole genome-hqSNPs in clonal ETEC O6 outbreaks ranged from 0 to 5. Of the 40 isolates tested for antimicrobial susceptibility, 18 isolates were pansusceptible. Twenty-two isolates were resistant to at least one antibiotic, nine of which were multidrug resistant. Phenotypic antimicrobial resistance (AR) correlated with AR determinants in 22 isolates. Thirty-two isolates harbored both enterotoxin virulence genes while the remaining 8 isolates had only one of the two virulence genes. In summary, whole genome-hqSNP and core genome SNP analyses from this study revealed similar evolutionary relationships and an overall diversity of ETEC O6 isolates independent of time of isolation. Less than 5 pairwise hqSNPs between ETEC O6 isolates is circumstantially indicative of an outbreak cluster. Findings from this study will be a basis for quicker outbreak detection and control by efficient subtyping by WGS.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30596673 PMCID: PMC6312315 DOI: 10.1371/journal.pone.0208735
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1ETEC O6 isolates are clustered into three clades by whole genome high-quality SNP analysis.
Whole genome high-quality single nucleotide polymorphisms (WG-hqSNP) tree generated by Lyve-SET for phylogenetic relatedness of 37 ETEC O6 isolates against the reference genome 2011EL1370-2. The scale represents a distance of 0.002 hqSNPs per site. At each ancestor node, bootstrap percentages are displayed. Isolates are clustered into Clade I, Clade II and Clade III. Isolates are color coded based on isolation during an outbreak (OB) or sporadic infection (S). In the metadata table, *CS stands for Cruise Ship; US states are abbreviated.
Fig 2ETEC O6 isolates are clustered into three clades by core genome SNP analysis.
Core genome single nucleotide polymorphisms (CG-SNP) tree generated by Parsnp for phylogenetic relatedness of 37 ETEC O6 isolates against the reference genome 2011EL1370-2. The scale represents a distance of 0.02 SNPs per site. Bootstrap percentages are displayed at each ancestor node. Isolates are clustered into Clade I, Clade II and Clade III. Isolates are color coded based on isolation during an outbreak (OB) or sporadic infection (S). In the metadata table, *CS stands for Cruise Ship; US states are abbreviated.
Median number of pairwise whole genome high-quality SNPs in ETEC O6 outbreaks are 0–4.5.
| Outbreak | Number of isolates | Median number of hqSNPs 1 | Predicted outbreak type |
|---|---|---|---|
| OB3 –clone 1 | 1 | - | Polyclonal |
| OB3 –clone 2 | 1 | - | Polyclonal |
| OB4 | 4 | 4.5 | Clonal |
| OB6 | 2 | 1 | Clonal |
| OB9, OB10 | 2 | 4 | Clonal |
| OB12 | 2 | 0 | Clonal |
| OB15 –clone 1 | 1 | - | Polyclonal |
| OB15 –clone 2 | 2 | 0 | Polyclonal |
| OB17, OB18-clone 1 | 2 | 1 | Clonal |
| OB18 –clone 2 | 1 | - | Polyclonal |
OB stands for outbreak. 1A dash in this column indicates that only one isolate for this clone was available for study and therefore the median could not be calculated.
Median number of pairwise whole genome high-quality SNPs in clusters of isolates from sporadic infections and outbreaks.
| Cluster number | CDC isolate ID (sporadic infection/outbreak number) | Median number of pairwise WG-hqSNPs |
|---|---|---|
| 1 | 2011EL1640-5 (S7), 2011EL1251-4 (OB 9), | 4 |
OB stands for outbreak; S stands for sporadic infection.
Phenotypic and genotypic antimicrobial resistance profiles of ETEC O6 isolates.
| CDC Isolate ID | Outbreak (OB)/Sporadic (S) infection number | Phenotypic resistance resistance profile | Resistance determinants |
|---|---|---|---|
| F5524 | OB5 | A,S,Su,T,Cot | |
| F5995 | OB6 | A,S,Su,Cot | |
| F6097 | OB6 | A,S,Su,Cot | |
| 2011EL1251-4 | OB9 | Nal | |
| 2011EL1497-2 | OB10 | Nal | |
| 2013EL1319-2 | OB12 | Nal | |
| 2013EL1320-5 | OB12 | Nal | |
| 2013EL1377-9 | OB13 | S,Su | |
| 2015EL1279-2 | OB15 | A,Su,Cot | |
| 2015EL1280-1 | OB15 | Nal | |
| 2015EL1281-1 | OB15 | Nal | |
| 2015EL1408-1 | OB16 | A,S,Su,Cot | |
| 2016EL1009-e | OB17 | Nal | |
| 2016EL1012-b | OB18 | Nal,Su,T,Cot | |
| 2016EL1014-a | OB18 | Nal | |
| SSU7785 | S1 | S,T | |
| 2011EL1640-5 | S7 | Nal | |
| 2012EL1587-5 | S8 | A,S,Su,T,Cot | |
| 2012EL1638-1 | S9 | Nal | |
| 2014EL1346-6 | S11 | Nal | |
| 2015EL1534-1 | S12 | A,S,Su,T,Cot | |
| 2015EL1559-2 | S13 | A,S,Su,T,Cot |
Fig 3Heat map visualization of phenotypic and genotypic antimicrobial resistance patterns of ETEC O6 isolates.
Phenotypic antimicrobial resistance and resistance determinants were visualized alongside WG-hqSNP phylogeny using the ggtree package in R. a). Phenotypic antimicrobial resistance patterns: AMP: Ampicillin; NAL: Nalidixic acid; STR: Streptomycin; SUL: Sulfisoxazole; TET: Tetracycline; TRI: trimethoprim-sulfamethoxazole. b). Genotypic resistance determinants: blaTEM-1B: beta-lactam resistance determinant; gyrA83, gyrA87: point mutations in S83L and D87Y in Gyrase A subunit of DNA Gyrase enzyme resulting in reduced binding of nalidixic acid; aadA1, strA, strB: streptomycin resistant determinants; sul1, sul2: sulphonamide resistance determinant; tetA, tetB: tetracycline resistance determinant; dfrA1, dfrA8 and dfrA15: trimethoprim-sulfamethoxazole resistance determinant; qnrS1: quinolone resistance determinant.